Skip to content
GenoLensGenoLens

DOHH

Chr 19p13.3

deoxyhypusine hydroxylase

Aliases:
MGC4293
MANE:
ENST00000427575.6

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Severe microcephaly

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment

    0.71
  • complex neurodevelopmental disorder

    0.37
  • neurodegenerative disease

    0.36
  • neurodevelopmental disorder

    0.19
  • prostate cancer

    0.03
  • prostate carcinoma

    0.03
  • Familial prostate cancer

    0.03
  • metabolic dysfunction-associated steatohepatitis

    0.03
  • glioblastoma

    0.02
  • colitis

    0.02

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Deoxyhypusine hydroxylase

Catalyzes the hydroxylation of the N(6)-(4-aminobutyl)-L-lysine intermediate produced by deoxyhypusine synthase/DHPS on a critical lysine of the eukaryotic translation initiation factor 5A/eIF-5A. This is the second step of the post-translational modification of that lysine into an unusual amino acid residue named hypusine (PubMed:16371467, PubMed:16533814, PubMed:19706422). Hypusination is unique to mature eIF-5A factor and is essential for its function (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.